- Home
- EDRY vs NTRB Comparison
EDRY vs NTRB Comparison
Compare EDRY & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDRY | NTRB |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.8M | 72.6M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | EDRY | NTRB |
|---|---|---|
| Price | $68.61 | $6.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 155.0K | 60.9K |
| Earning Date | 06-04-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,036,651.00 |
| Revenue This Year | $28.30 | $30.17 |
| Revenue Next Year | $10.13 | $3,394.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.21 | $2.80 |
| 52 Week High | $71.84 | $8.63 |
Technical Indicators
Market Signals| Indicator | EDRY | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 76.31 | 77.57 |
| Support Level | $17.37 | $4.18 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 5.21 | 0.61 |
| MACD | 0.82 | 0.18 |
| Stochastic Oscillator | 81.48 | 92.04 |
Price Performance
Historical ComparisonAbout EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.